SCHEMBL10260320

SCHEMBL10260320

Cc1ccc(-c2c3cc(F)c(=O)cc-3oc3cc(O)c(F)cc23)c(C(=O)O)c1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 2/20 0.76
POLB P06746 7/20 0.48
KDM4E B2RXH2 6/20 0.48
USP2 O75604 7/20 0.47
MEN1 O00255 7/20 0.47
KMT2A Q03164 7/20 0.47
BLM P54132 6/20 0.47
MAPT P10636 6/20 0.47
RECQL P46063 5/20 0.47
TDP1 Q9NUW8 5/20 0.47
HPGD P15428 5/20 0.47
THRB P10828 4/20 0.47
HTT P42858 3/20 0.47
CASP7 P55210 2/20 0.47
CYP3A4 P08684 1/20 0.47
ALOX15 P16050 1/20 0.47
CASP1 P29466 1/20 0.47
BRCA1 P38398 1/20 0.47
L3MBTL1 Q9Y468 6/20 0.42
GAA P10253 5/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17695445 0.92 FTO (0.76) FTOPOLBKDM4EUSP2MEN1
SCHEMBL31435692 0.89 FTO (0.78) FTOPOLBKDM4EUSP2MEN1
SCHEMBL3109289 0.89 FTO (0.78) FTOPOLBKDM4EUSP2MEN1
SCHEMBL21129885 0.89 FTO (0.74) FTOPOLBKDM4EUSP2MEN1
SCHEMBL17972575 0.88 FTO (0.77) FTOPOLBKDM4EUSP2MEN1
SCHEMBL24274861 0.88 FTO (0.76) FTOPOLBKDM4EUSP2MEN1
SCHEMBL18650245 0.87 FTO (0.65) FTOPOLBKDM4EUSP2MEN1
SCHEMBL21126672 0.87 FTO (0.71) FTOPOLBKDM4EUSP2MEN1
SCHEMBL22702333 0.87 FTO (0.71) FTOPOLBKDM4EUSP2MEN1
SCHEMBL18972336 0.87 FTO (0.74) FTOPOLBKDM4EUSP2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020185610-A1 NEW TECHNOLOGY TO CONJUGATE THE TACCALONOLIDE MICROTUBULE STABILIZERS WITH LINKERS/PAYLOADS DU LIN (US) 2020-09-17 WO disclosed
US-8211934-B2 Small molecule inhibition of PDZ-domain interaction THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-07-03 US disclosed
US-20110160263-A1 Small molecule inhibition of PDZ-domain interaction THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2011-06-30 US disclosed
US-7795295-B2 Small molecule inhibition of PDZ-domain interaction THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-09-14 US disclosed
US-7601750-B2 Small molecule inhibition of a PDZ-domain interaction THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-10-13 US disclosed
US-20080064733-A1 Small Molecule Inhibition of Pdz-Domain Interaction THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2008-03-13 US disclosed
US-20080021082-A1 Small molecule inhibition of a PDZ-domain interaction THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064733-A1 Small Molecule Inhibition of Pdz-Domain Interaction DVL1, DVL3, PDLIM5 FTO 4534/4885POLB 4632/4885KDM4E 2901/4885
US-20080021082-A1 Small molecule inhibition of a PDZ-domain interaction DVL1, DVL3, PDLIM5 FTO 4386/4885POLB 4726/4885KDM4E 2656/4885
US-20110160263-A1 Small molecule inhibition of PDZ-domain interaction DVL1, DVL3, PDLIM5 FTO 4448/4885POLB 4649/4885KDM4E 2852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.